ArticleFrontiers in pharmacology2021

Glycyrrhizic Acid for COVID-19: Findings of Targeting Pivotal Inflammatory Pathways Triggered by SARS-CoV-2.

Wenjiang Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.